Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,301–8,325 of 27,380 studies, newest first · page 333 of 1096.

November 2022 25

  1. 2022-11-10

    Drug repurposing using meta-analysis of gene expression in Alzheimer's disease

    ✓ Peer-reviewed Drug development Frontiers in neuroscience

    Key finding: Reversal genes and the candidate compounds were identified by the leave-one-out cross-validation procedure. +2 more findings

  2. 2022-11-10
  3. 2022-11-10

    Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

    ✓ Peer-reviewed Mild cognitive impairment Nature medicine

    Key finding: Cox proportional-hazards models showed a substantially increased risk for progression to mild cognitive impairment in the A + T NEO-T + (hazard ratio (HR) = 19.2, 95% confidence interval (CI) = 10.9-33.7), A + T MTL + (HR = 14.6, 95% CI = 8.1-26.4) and A + T - (HR = 2.4, 95% CI = 1.4-4.3) groups versus the A - T - (reference) group. +2 more findings

  4. 2022-11-09

    Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid

    ✓ Peer-reviewed Genetics Nature

    Key finding: We identify a subpopulation of PBMs that express high levels of CD163 and LYVE1 (scavenger receptor proteins), closely associated with the brain arterial tree, and show that LYVE1 + PBMs regulate arterial motion that drives CSF flow. +1 more finding

  5. 2022-11-09

    Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Mitochondrion

    Key finding: Collectively, the mitochondrial abnormalities and altered energy metabolism perturbs several signaling pathways, particularly related to neurogenesis, which are directly associated with cognitive development and early onset of AD in individuals with DS.

  6. 2022-11-08

    Can Alzheimer's Disease Be Secondary to Type-2 Diabetes Mellitus?

    ✓ Peer-reviewed Risk factors Cureus

    Key finding: First, it was shown that insulin receptors are present in the brain, namely the hippocampus. +2 more findings

  7. 2022-11-08

    Unsupervised mobile app-based cognitive testing in a population-based study of older adults born 1944

    ✓ Peer-reviewed Cognitive tests and assessment Frontiers in digital health

    Key finding: MDT-OS and ORR-LDR were weakly-to-moderately correlated with the Preclinical Alzheimer's Cognitive Composite (PACC5) (r = 0.3-0.44, p < .001) and with several other measures of episodic memory, processing speed, and executive function. +4 more findings

  8. 2022-11-08

    ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies

    ✓ Peer-reviewed How common it is Molecular neurodegeneration

    Key finding: While the ε4 allele of the APOE gene significantly increases AD risk, the ε2 allele is protective relative to the common ε3 allele.

  9. 2022-11-07

    The importance of estradiol for body weight regulation in women

    ✓ Peer-reviewed Drug development Frontiers in endocrinology

    Key finding: It is associated with increased menstrual irregularity, ovulatory dysfunction, development of insulin resistance and infertility.

  10. 2022-11-07

    Hearing impairment is associated with cognitive decline, brain atrophy and tau pathology

    ✓ Peer-reviewed Long-term cohort studies EBioMedicine

    Key finding: Hearing impairment was recently identified as the most prominent risk factor for dementia. +3 more findings

  11. 2022-11-07

    Vascular endothelial-cadherin as a marker of endothelial injury in preclinical Alzheimer disease

    ✓ Peer-reviewed Biomarkers Annals of clinical and translational neurology

    Key finding: Our results support the utility of CSF VEC as a marker of endothelial injury in AD and highlight the importance of endothelial injury as an early pathology that contributes to cognitive impairment in even the earliest preclinical stages. +2 more findings

  12. 2022-11-05

    Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia

    ✓ Peer-reviewed Brain scans and imaging Human brain mapping

    Key finding: Its expression in bvFTD patients was significantly higher compared to HC and other dementia syndromes (p < .0004), correlated with cognitive decline (p = .0001), and increased over time in longitudinal cohort (p = .0007). +3 more findings

  13. 2022-11-04

    Diverse limbic comorbidities cause limbic and temporal atrophy in lewy body disease

    ✓ Peer-reviewed Brain tissue and pathology Parkinsonism & related disorders

    Key finding: The mean age at antemortem magnetic resonance imaging of the mLBD patients was higher than that of the pLBD patients (84.3 ± 3.9 vs. 76.5 ± 10.5; p = .046). +4 more findings

  14. 2022-11-04

    Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease

    ✓ Peer-reviewed Treatments Nature communications

    Key finding: Using human cross-sectional and longitudinal neuroimaging and cognitive assessment data, we show that in early stages of AD, increased concentration of soluble CSF p-tau is strongly associated with accumulation of insoluble tau aggregates across the brain, and CSF p-tau levels mediate the effect of Aβ on tau aggregation. +2 more findings

  15. 2022-11-03

    Attitudes toward Alzheimer's disease and dementia caregiving and health outcomes: Racial and ethnic differences

    ✓ Peer-reviewed Disparities Geriatric nursing (New York, N.Y.)

    Key finding: There were significant racial/ethnic differences in caregivers' attitudes toward dementia caregiving, health-related quality of life, and total severity scores of symptoms (p < .01). +1 more finding

  16. 2022-11-03

    SPARE-Tau: A flortaucipir machine-learning derived early predictor of cognitive decline

    ✓ Peer-reviewed Brain scans and imaging PloS one

    Key finding: Compared to CSF p-tau, meta-temporal, and averaged Braak tau PET ROIs, SPARE-Tau showed the strongest association with baseline ADAS-cog13 scores and diagnosis. +4 more findings

  17. 2022-11-03

    A single-cell transcriptome atlas of glial diversity in the human hippocampus across the postnatal lifespan

    ✓ Peer-reviewed Genetics Cell stem cell

    Key finding: Detailed analyses of astrocytes, oligodendrocyte lineages, and microglia identified subpopulations with distinct molecular signatures and revealed their association with specific physiological functions, age-dependent changes in abundance, and disease relevance. +2 more findings

  18. 2022-11-03

    The association between cerebrospinal ferritin and soluble triggering receptor expressed on myeloid cells 2 along Alzheimer's continuum

    ✓ Peer-reviewed TREM2 and immune genetics Frontiers in neurology

    Key finding: Brain iron accumulation, which is indicated in the cerebrospinal fluid (CSF) ferritin, is associated with the development of Alzheimer's Disease (AD). +3 more findings

  19. 2022-11-03

    Sex-specific biomarkers in Alzheimer's disease progression: Framingham Heart Study

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: During 11 years of follow-up, women were 96% more likely than men to be diagnosed with clinical AD dementia after adjusting for age and education in the younger age group 60 to 70 years (n = 946; 95% confidence interval [CI], 1.08 to 3.56) although not in the older age group (70+) (n = 452; hazard ratio = 0.98; 95% CI, 0.68 to 1.53). +4 more findings

  20. 2022-11-03

    Association of cognitive function with Neurofilament light chain in the aqueous humor of human eye

    ✓ Peer-reviewed Biomarkers Frontiers in aging neuroscience

    Key finding: NfL, Aβ40, Aβ42, GFAP, and p-tau181 were detected in all AH samples by Simoa platform. +4 more findings

  21. 2022-11-03

    Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults

    ✓ Peer-reviewed Tau biomarkers Brain communications

    Key finding: Epidemiological and experimental data point to sleep abnormalities contributing to the risk of Alzheimer's disease. +3 more findings

  22. 2022-11-03

    Classification of Alzheimer's disease and frontotemporal dementia using routine clinical and cognitive measures across multicentric underrepresented samples: A cross sectional observational study

    ✓ Peer-reviewed Digital health tools Lancet regional health. Americas

    Key finding: A fully automated computational approach included classical statistical methods, support vector machine procedures, and machine learning techniques (random forest and sequential feature selection procedures). +3 more findings

  23. 2022-11-03

    Risk factors for dementia in Brazil: Differences by region and race

    ✓ Peer-reviewed Disparities Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Brazil's potential for dementia prevention is higher than in HIC.

  24. 2022-11-03

    Fast and Accurate Amyloid Brain PET Quantification Without MRI Using Deep Neural Networks

    ✓ Peer-reviewed Biomarkers Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    Key finding: Quantification results using the proposed deep learning-based method showed stronger correlations with the FreeSurfer estimates than SPM-based SN using MRI did. +4 more findings

  25. 2022-11-02

    The intestinal barrier in disorders of the central nervous system

    ✓ Peer-reviewed Disease mechanisms The lancet. Gastroenterology & hepatology

    Key finding: Mounting evidence now suggests that the intestinal barrier is compromised not only in digestive disorders, but also in disorders of the central nervous system (CNS), such as Parkinson's disease, autism spectrum disorder, depression, multiple sclerosis, and Alzheimer's disease.

Browse the library by subject, with the full score breakdown →